|[March 18, 2014]
Trendlines Labs Signs Collaboration Agreement with Sheba Medical Center, the Largest Hospital in Israel and in the Middle East
TEL AVIV, Israel --(Business Wire)--
Within the framework of a new collaboration agreement, Trendlines Labs
will take part in developing new devices to meet clinical needs
identified by doctors at Sheba Medical Center.
Labs, the in-house invention unit of The
Trendlines Group, focuses on inventing medical technologies to meet
critical unmet needs.
Chaim Sheba Medical Center (SMC) at Tel-Hashomer, Israel is the
largest and most comprehensive medical center in the Middle East where
close to 7,000 healthcare professionals perform around 4 million
procedures to over 1 million atients per year. SMC combines six major
facilities: a vast medical research complex, medical education academic
campus, acute care hospital, children's hospital, women's hospital and
the country's main rehabilitation hospital.
Alongside emphasizing compassionate patient care, the Sheba campus
combines innovative scientific research, comprehensive medical training
and teaching. SMC is also a major medical-scientific research powerhouse
that collaborates internationally with the biotech and pharmaceutical
industries to develop new drugs, treatments and technologies, and a
foremost global center for medical education. It is a
university-affiliated tertiary referral hospital that serves as Israel's
national medical center in many fields.
Together with the hospital's research staff and world-renowned
physicians, Trendlines Labs collaborates in the development of new ideas
and intellectual property. This collaboration with Trendlines Labs
brings together a multidisciplinary team of technology experts with
medical professionals to develop innovative solutions for unmet clinical
needs. Trendlines Labs cooperates with doctors during any stage of
product development from proof of concept through to prototype.
Dr. David Shashar, manager of the Medical Device Invention Unit at
the Sheba Medical Center's Technology Transfer Company:
"Constructing collaborations at SMC is aimed at accelerating the
development of cost-effective technological solutions to pressing
clinical problems. We believe in embracing team work in the problem
solution process between those who know the clinical issues and those
who know available technologies well, to achieve widespread adoption of
the best ideas, evaluation of projects and proof of efficacy. Working
with Trendlines Labs has been an exciting and outstanding opportunity
for innovative physicians from our medical staff. The Trendlines Labs
team is exceptional in their experience, knowledge, untraditional
thinking and their capabilities to move projects forward. From the stage
of a general idea, we have progressed in a number of projects to
prototype development, bench studies, animal trials and early human
Yosi Hazan, CEO of Trendlines Labs: "This collaboration follows
two recent agreements for Trendlines Labs: one with a major U.S.
hospital and another with a key health organization in Israel. It is
further evidence of the extent and interest of hospitals in seeking
collaborative efforts like those we offer at Trendlines Labs. Our
solutions are global, not local. We are currently in discussions with
hospitals in the United States and Canada in the hopes of signing more
agreements of this nature."
[ Back To TMCnet.com's Homepage ]